MMarkets Read More Jim Cramer’s Monday playbook after the stock market’s Fed-driven rip higher24 August 2025 The conundrum of the stock market going down ahead of Jackson Hole confounded me. With a market that…
EEU Read More US-EU trade deal impacts on pharma industry more ‘manageable’ than expected21 August 2025 A 15% import tariff on pharmaceutical goods from the European Union to the US is going to have…
MMarkets Read More Stocks power to record highs again despite warning signs. Can the market’s strong run continue?16 August 2025 The market wants a Federal Reserve interest-rate cut soon, but it doesn’t want to need one. Wall Street…
MMedication Read More Pharma firm defends online-only warning for antibiotic10 August 2025 A Johannesburg man who suffered four tendon ruptures has accused Cipla Medpro of deliberately not disclosing adverse events…
UUnited States Read More Trump asks drugmakers to cut U.S. prices within 60 days31 July 2025 U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz,…
MMarkets Read More Wall Street quietly mixed as corporate earnings pour in, offering a respite from tariff anxiety16 July 2025 Early trading on Wall Street was quietly mixed on Wednesday as markets shift their attention toward a deluge…
MMarkets Read More Stock market today: Live updates16 July 2025 Traders work on the floor of the New York Stock Exchange moments before the Closing Bell and the…
MMarkets Read More Stock market today: Live updates2 July 2025 Traders work on the floor of the New York Stock Exchange during morning trading on April 07, 2025…
BBristol Read More We are lowering our Bristol Myers price target despite an earnings beat24 April 2025 Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock.…
BBristol Read More Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect24 April 2025 Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing…